Details of the Drug Reposition

General Information of This Drug (ID: DM1TWIE)

Drug Name
CFZ533   DM1TWIE

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Sjogren syndrome DISUBX7H 4A43.20 Phase 2 [1]
Graves disease DISU4KOQ 5A02.0 Phase 2 [1]
Myasthenia gravis DISELRCI 8C6Y Phase 2 [1]
Rheumatoid arthritis DISTSB4J FA20 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02291029) Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sj ren's Syndrome. U.S. National Institutes of Health.